BE816573Q - Medicament containing a pyridoxine derivative - Google Patents

Medicament containing a pyridoxine derivative

Info

Publication number
BE816573Q
BE816573Q BE145632A BE145632A BE816573Q BE 816573 Q BE816573 Q BE 816573Q BE 145632 A BE145632 A BE 145632A BE 145632 A BE145632 A BE 145632A BE 816573 Q BE816573 Q BE 816573Q
Authority
BE
Belgium
Prior art keywords
pyridoxine
alpha
medicament containing
pyridoxine derivative
vitaminising
Prior art date
Application number
BE145632A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of BE816573Q publication Critical patent/BE816573Q/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C07D213/67—2-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

Medicament contg. as active ingredient pyridoxine-alpha-ketoglutarate of formula I. Detoxicant, liver-protecting, neurasthenic, eutrophic and vitaminising agent. For oral, parenteral and rectal administration in appropriate vehicles. By reaction of alpha-ketoglutaric acid and pyridoxine, pref. in the presence of small amts. of acetone-diMe-acetal in MeOH soln. The product is pptd. by adding i-propyl ether.
BE145632A 1967-06-13 1974-06-19 Medicament containing a pyridoxine derivative BE816573Q (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR110092A FR6453M (en) 1967-06-13 1967-06-13

Publications (1)

Publication Number Publication Date
BE816573Q true BE816573Q (en) 1974-10-16

Family

ID=8632871

Family Applications (1)

Application Number Title Priority Date Filing Date
BE145632A BE816573Q (en) 1967-06-13 1974-06-19 Medicament containing a pyridoxine derivative

Country Status (2)

Country Link
BE (1) BE816573Q (en)
FR (1) FR6453M (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1141070B (en) * 1980-09-22 1986-10-01 Luso Farmaco Inst USE OF ALPHA-KETOGLUTARATE OF PYRIDOXY IN THE PROPHYLAXIS OF HYPERLACTACIDEMIA
DE60023125T2 (en) 1999-03-08 2006-06-22 University Of Manitoba, Winnipeg PYRIDOXAL ANALOGUE FOR THE TREATMENT OF DISORDERS RELEASED BY A VITAMIN B6 LACK
EP1872797A3 (en) 1999-08-24 2008-04-02 Medicure International Inc. Treatment of cardiovascular and related pathologies
EP1268498B1 (en) 2000-02-29 2005-04-13 Medicure International Inc. Cardioprotective phosphonates
AU784840B2 (en) 2000-03-28 2006-07-06 Medicure International Inc. Treatment of cerebrovascular disease
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US7812037B2 (en) 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs

Also Published As

Publication number Publication date
FR6453M (en) 1968-11-12

Similar Documents

Publication Publication Date Title
NL141515B (en) PROCESS FOR THE PREPARATION OF AN ANTIBIOTIC ACTIVE PREPARATION BY PREPARING A 7- (ALPHA-AMINOPHENYLACETYLAMINO) -DELTA3-CEFEM-4-CARBONIC ACID DERIVATIVE IN A FORM SUITABLE FOR THERAPEUTIC ADMINISTRATION AND PREPARATION OF THE PREPARATION OF PREPARATION.
ES412813A1 (en) 3-Substituted-1,2-benzisoxazoles and pharmaceutically acceptable acid addition salts thereof
BE816573Q (en) Medicament containing a pyridoxine derivative
GB1173227A (en) Amino-Isoquinolines
ES431497A1 (en) S-triazolo(1,5-a)pyridine derivative
ES432027A1 (en) Pharmacologically active anilinobenzothiazoles
NL160722C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION BY CONTAINING A 6,6-DIFLUORSTEROID IN A FORM SUITABLE FOR THERAPEUTIC ADMINISTRATION, AND FORMED PREPARATION AND PROCEDURE FOR PREPARING THE ACTIVE COMPOUNDS.
GB1124390A (en) Process for manufacturing therapeutically active derivatives of ªÐ-dihydroxybenzene
GB1104145A (en) Pyrazolo-pyridine derivatives
GB1126153A (en) Novel polygalacturonic acid derivative
GB1178012A (en) A Method for the Production of Pyridine Derivatives
JPS5273876A (en) Synthesis of carbostyril derivatives
ES377523A1 (en) Compound of germanic acid and cysteine
FR2129914A2 (en) Sulphonic acid salts of aliphatic diamines - with antiviral activity
GB1020073A (en) A salt of nicotinic acid
FR2092785A1 (en) 2-azaquinolizidine derivs and salts neurotropic and anti - -histamine agents synthesis
GB1321692A (en) Dihydro-3-piperidyl-2 3h-furanone derivatives
JPS51136818A (en) Method for preparing stable prostaglandine pharma ceuticals
FR2223022A1 (en) 4-Biphenyl-4-hydroxy-crotonic acid lactone - useful as an anti-inflammatory agent
GB1223445A (en) Improvements in or relating to derivatives of morphine, their salts, and processes for their preparation
FR2081580A1 (en) Pharmacol-active 2,4,6-trimethoxybenzoates
GB1070310A (en) 4-aminoquinoline derivatives
GB1185458A (en) Salicylanilide Derivatives
ES351412A2 (en) Pyridyl-3,3-di-lower alkyl-3,4-dihydro-isoquinolines
ES340846A1 (en) Reserpine 3,5,3'-triiodothyroacetate